All In Biotech

Free tool

FAERS Monitor: Auvi-Q

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 19, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 201739 or its brand name (Auvi-Q, Epinephrine). Reports on generic versions are filed under their own applications.

Reports

43,337

Serious

26,523

61% of reports

Hospitalization

14,066

Death reported

3,554

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective4,644
  • headache3,108
  • sinusitis2,928
  • fatigue2,823
  • product dose omission issue2,800
  • pain2,512
  • covid-192,434
  • dyspnoea2,295
  • nausea2,255
  • off label use2,096
  • pneumonia2,078
  • inappropriate schedule of product administration1,794
  • nasopharyngitis1,686
  • pyrexia1,670
  • cough1,598

Reports by year received

View as table
YearReports
2004133
2005118
2006136
2007166
2008194
2009269
2010261
2011702
2012425
2013316
2014450
2015693
20161,121
20171,606
20182,536
20193,428
20206,560
20213,969
20223,701
20233,884
20244,553
20254,798
20263,315

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,010,822 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
sinusitisSignal2,92814.213.735,185
covid-19Signal2,4346.86.612,001
inappropriate schedule of product administrationSignal1,7944.94.75,505
product dose omission issueSignal2,8004.74.58,071
nasopharyngitisSignal1,6864.54.34,538
pneumoniaSignal2,0783.13.03,035
coughSignal1,5982.82.61,828
headacheSignal3,1082.42.32,636
pyrexiaSignal1,6702.32.21,308
pain2,5122.01.91,266
dyspnoea2,2952.01.91,124
fatigue2,8231.81.7963
drug ineffective4,6441.71.71,463
nausea2,2551.41.3248
off label use2,0961.21.149

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.